Przejdź do treści Wyszukiwarka Kontakt
sss

MEET OUR PARTNERS: DEPARTMENT OF THORACIC SURGERY, MEDICAL UNIVERSITY OF GDAŃSK

ICCVS establishes numerous scientific collaborations with Polish and international partners. Today we would like to introduce Department of Thoracic Surgery from Medical University of Gdańsk. Cancer Immunology group collaborates closely with professor Witold Rzyman – head of the Department and doctor Tomasz Marjański in research on new therapeutic and diagnostic approaches in non-small cell lung cancer.

MEET OUR PARTNERS: IMMUNOLAB LTD.

This week we are presenting another of our partners – IMMUNOLAB from Gdańsk.   The main focus of our collaboration is to improve health and welfare of animals. We have already submitted a joint R&D application on the development of the next generation vaccine against African Swine Fever Virus. More information: Immunolab: https://immunolab.com.pl

UGRANTS FIRST FUNDING FOR DR ZUZANNA URBAN-WÓJCIUK

Dr Zuzanna Urban-Wójciuk from ICCVS was awarded with UGrants First funding. The goal of UGrants First initiative is to increase the number of research projects at the University of Gdansk by supporting researchers in obtaining their first external research grant.   Dr Urban-Wójciuk is planning to use these funds to perform preliminary experiments to test the impact of Toll-like receptor 9 (TLR-9) stimulation on NK cells and the

COOPERATION BETWEEN THE UNIVERSITY OF GDAŃSK AND THE UNIVERSITY OF MALTA IN THE FIELD OF CANCER IMMUNOTHERAPY

The cooperation between the International Centre for Cancer Vaccine Science, University of Gdańsk and the University of Malta was the main topic of the online meeting, which took place on April 20, 2021.   What cooperation is based on – interdisciplinary training and exchange under the ERASMUS program, joint development projects, joint study programs and seminars, and
Fundusze Europejskie Inteligentny Rozwój Flaga Rzeczpospolita Polska Europejski Fundusz Rozwoju Regionalnego

Program Międzynarodowe Agendy Badawcze jest realizowany przez Fundację na rzecz Nauki Polskiej ze środków funduszy strukturalnych w ramach Programu Operacyjnego Inteligentny Rozwój (PO IR) 2014–2020, Działanie 4.3. Międzynarodowe Agendy Badawcze.

© 2021 nFinity | Wszelkie prawa zastrzeżone